Overview

LC-MS metabolomics combines the separation power of liquid chromatography with the detection specificity of mass spectrometry to profile metabolites in complex biological samples. Liquid chromatography separates metabolites based on their physicochemical properties — typically hydrophobicity in reversed-phase or polarity in hydrophilic interaction liquid chromatography (HILIC) — before they enter the mass spectrometer. This two-dimensional separation (retention time plus m/z) enables the detection of thousands of metabolite features in a single run. LC-MS metabolomics has become the dominant platform for untargeted metabolic profiling due to its broad coverage of chemically diverse metabolites.

Methods

Reversed-phase LC separates non-polar to moderately polar metabolites using C18 columns with aqueous-organic gradients, making it ideal for lipids, amino acids, and small organic acids. HILIC retains polar metabolites such as sugars, nucleotides, and organic phosphates that are poorly retained on reversed-phase columns. High-resolution mass spectrometry — using quadrupole-Orbitrap or quadrupole-time-of-flight (QTOF) instruments — provides accurate mass measurement within 1-5 ppm, enabling confident molecular formula assignment. Data acquisition is performed in full-scan mode for untargeted profiling or in targeted modes such as parallel reaction monitoring for quantitative assays.

Applications

LC-MS metabolomics is used in clinical research to identify metabolite biomarkers for diseases including cancer, diabetes, and neurodegenerative disorders. In drug development, it measures the metabolomic response to pharmacological intervention. Environmental metabolomics applies LC-MS to assess organismal responses to pollutants and stressors. The technique integrates HPLC separation principles with mass spectrometry detection and follows sample preparation techniques that are critical for preserving metabolite integrity and reproducibility.